J&J’s 7.7% OTC Sales Growth Drives Consumer Business Turnaround
This article was originally published in The Tan Sheet
Executive Summary
Johnson & Johnson reports second-quarter OTC sales increased 7.7% to $1 billion, helping the firm’s overall consumer business sales grow 2.4% to $3.74 billion. CEO Alex Gorsky says J&J has a broad approach, including collaborations with other firms, for greater consumer sales growth.